Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide be-yond 2.5 years: A case series

A. Loglio,P. Ferenci,S. C. Uceda Renteria,H. Holzmann,M. Borghi,R. Perbellini,A. Rimondi,E. Trombetta,S. Giovanelli,L. Porretti,D. Prati,F. Ceriotti,P. Lampertico

DIGESTIVE AND LIVER DISEASE（2021）

引用 0|浏览5

暂无评分

摘要

Introduction: While the efficacy and safety of Bulevirtide (BLV) treatment for 48 weeks in compensated HDV cirrhotic patients has been already demonstrated, the long-term effects of this treatment have not been investigated yet.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要